Dysregulation of FMRP/mTOR Signaling Cascade in Hypoxic-Ischemic Injury of Premature Human Brain

Journal of Child Neurology

Volumn 31, Issue 4, 2016, Pages 426-432

  Lechpammer, Mirna ^a,b   Wintermark, Pia ^b,c   Merry, Katherine M ^b   Jackson, Michele C ^b   Jantzie, Lauren L ^b,d   Jensen, Frances E ^b,e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c MCGILL UNIVERSITY   (Canada)

^d UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

autism; brain injury; fragile X mental retardation protein; hypoxia; mammalian target of rapamycin; prematurity

Indexed keywords

FRAGILE X MENTAL RETARDATION PROTEIN; MAMMALIAN TARGET OF RAPAMYCIN; PROTEIN S6; FMR1 PROTEIN, HUMAN; MTOR PROTEIN, HUMAN; TARGET OF RAPAMYCIN KINASE;

ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GRAY MATTER; HUMAN; HUMAN TISSUE; HYPOXIC ISCHEMIC ENCEPHALOPATHY; IMMUNOHISTOCHEMISTRY; MALE; NEWBORN; PREMATURITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; WESTERN BLOTTING; BRAIN; GROWTH, DEVELOPMENT AND AGING; METABOLISM; MIDDLE AGED; PATHOLOGY; PILOT STUDY;

BLOTTING, WESTERN; BRAIN; FEMALE; FRAGILE X MENTAL RETARDATION PROTEIN; HUMANS; HYPOXIA-ISCHEMIA, BRAIN; IMMUNOHISTOCHEMISTRY; INFANT, NEWBORN; MALE; MIDDLE AGED; PILOT PROJECTS; SIGNAL TRANSDUCTION; TOR SERINE-THREONINE KINASES;

EID: 84957990168     PISSN: 08830738     EISSN: 17088283     Source Type: Journal    
DOI: 10.1177/0883073815596617     Document Type: Article

References (21)

1. Volpe JJ,. The encephalopathy of prematurity-brain injury and impaired brain development inextricably intertwined. Semin Pediatr Neurol. 2009; 16: 167-178.
2. Haynes RL, Sleeper LA, Volpe JJ, Kinney HC,. Neuropathologic studies of the encephalopathy of prematurity in the late preterm infant. Clin Perinatol. 2013; 40 (4): 707-722.
3. Glasson EJ, Bower C, Petterson B, de Klerk N, Chaney G, Hallmayer JF,. Perinatal factors and the development of autism: a population study. Arch Gen Psychiatry. 2004; 61: 618-627.
4. Follett PL, Deng W, Dai W, et al. Glutamate receptor-mediated oligodendrocyte toxicity in periventricular leukomalacia: a protective role for topiramate. J Neurosci. 2004; 24: 4412-4420.
5. Jensen FE,. Role of glutamate receptors in periventricular leukomalacia. J Child Neurol. 2005; 20: 950-959.
6. Maramara LA, He W, Ming X,. Pre- and perinatal risk factors for autism spectrum disorder in a New Jersey cohort. J Child Neurol. 2014; 29: 1645-1651.
7. Hagerman RJ, Hoem G, Hagerman P, Fragile X, and autism: Intertwined at the molecular level leading to targeted treatments. Mol Autism. 2010; 1: 12-26.
8. Loesch DZ, Huggins RM, Hagerman RJ,. Phenotypic variation and FMRP levels in fragile X. Ment Retard Dev Disabil Res Rev. 2004; 10: 31-41.
9. Ma XM, Blenis J,. Molecular mechanisms of mTOR-mediated translational control. Nat Rev Mol Cell Biol. 2009; 10: 307-318.
10. Sharma A, Hoeffer CA, Takayasu Y, et al. Dysregulation of mTOR signaling in fragile X syndrome. J Neurosci. 2010; 30: 694-702.
11. Jensen FE,. Developmental factors regulating developmental susceptibility to perinatal brain injury and seizures. Curr Opin Pediatr. 2006; 18: 628-633.
12. Jantzie LL, Talos DM, Selip DB, et al. Developmental regulation of group I metabotropic glutamate receptors in the premature brain and their protective role in a rodent model of periventricular leukomalacia. Neuron Glia Biol. 2010; 6: 277-288.
13. Dolen G, Bear MF,. Role for metabotropic glutamate receptor 5 (mGluR5) in the pathogenesis of fragile X syndrome. J Physiol. 2008; 586: 1503-1508.
14. Lechpammer M, Manning SM, Samonte F, et al. Minocycline treatment following hypoxic/ischaemic injury attenuates white matter injury in a rodent model of periventricular leucomalacia. Neuropathol Appl Neurobiol. 2008; 34: 379-393.
15. Wintermark P, Lechpammer M, Warfield SK, et al. Perfusion imaging of focal cortical dysplasia using arterial spin labeling: correlation with histopathological vascular density. J Child Neurol. 2013; 11: 1474-1482.
16. Lechpammer M, Clegg MS, Muzar Z, Huebner PA, Jin LY, Gospe SM Jr,. Pathology of inherited manganese transporter deficiency. Ann Neurol. 2014; 75: 608-612.
17. de Jong M, Verhoeven M, van Baar AL,. School outcome, cognitive functioning, and behaviour problems in moderate and late preterm children and adults: a review. Semin Fetal Neonatal Med. 2012; 17: 163-169.
18. Kugelman A, Colin AA,. Late preterm infants: near term but still in a critical developmental time period. Pediatrics. 2013; 132: 741-751.
19. Takei N, Nawa H. mTOR signaling and its roles in normal and abnormal brain development. Front Mol Neurosci. 2014; 7: 28.
20. Romano C, Sesma MA, McDonald CT, O'Malley K, Van den Pol AN, Olney JW,. Distribution of metabotropic glutamate receptor mGluR5 immunoreactivity in rat brain. J Comp Neurol. 1995; 355 (3): 455-469.
21. Kanold PO, Shatz CJ,. Subplate neurons regulate maturation of cortical inhibition and outcome of ocular dominance plasticity. Nuron. 2006; 51: 627-638.